Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 442

1.

Current Results of Surgical Aortic Valve Replacement: Insights From the German Aortic Valve Registry.

Holzhey D, Mohr FW, Walther T, Möllmann H, Beckmann A, Kötting J, Figulla HR, Cremer J, Kuck KH, Lange R, Sack S, Schuler G, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Hamm CW.

Ann Thorac Surg. 2016 Feb;101(2):658-66. doi: 10.1016/j.athoracsur.2015.07.090. Epub 2015 Nov 11.

PMID:
26576751
2.
3.

Intravital microscopy -A novel toolin characterizing congestive heart failurein experimental autoimmune myocarditis.

Pistulli R, Quitter F, Andreas E, Rohm I, Kretzschmar D, Figulla HR, Yilmaz A, Jung C.

Clin Hemorheol Microcirc. 2015 Oct 16. [Epub ahead of print]

PMID:
26484717
4.

Impact of Systemic Normobaric Short-Term Hypoxia on Pro-Inflammatory and Anti-Inflammatory Cytokines in Healthy Volunteers.

Rohm I, Ratka J, Pistulli R, Goebel B, Gecks T, Figulla HR, Yilmaz A, Jung C.

Clin Lab. 2015;61(8):1053-9.

PMID:
26427151
5.

The association between endothelial microparticles and inflammation in patients with systemic sclerosis and Raynaud's phenomenon as detected by functional imaging.

Jung C, Drummer K, Oelzner P, Figulla HR, Boettcher J, Franz M, Betge S, Foerster M, Wolf G, Pfeil A.

Clin Hemorheol Microcirc. 2016;61(3):549-57. doi: 10.3233/CH-151956.

PMID:
26410864
6.

Development and characterization of an ex vivo arterial long-term proliferation model for restenosis research.

Haase D, Otto S, Romeike BF, Figulla HR, Poerner TC.

ALTEX. 2015;32(4):307-17. doi: http://dx.doi.org/10.14573/altex.1503051. Epub 2015 Sep 24.

7.

Cardiomyogenesis of embryonic stem cells upon purinergic receptor activation by ADP and ATP.

Mazrouei S, Sharifpanah F, Bekhite MM, Figulla HR, Sauer H, Wartenberg M.

Purinergic Signal. 2015 Dec;11(4):491-506. doi: 10.1007/s11302-015-9468-1. Epub 2015 Sep 22.

PMID:
26395809
8.

Tricuspid valve interventions in 2015.

Lauten A, Figulla HR.

EuroIntervention. 2015 Sep;11 Suppl W:W133-6. doi: 10.4244/EIJV11SWA37.

9.

Impact of diabetes mellitus and its complications: survival and quality-of-life in critically ill patients.

Bannier K, Lichtenauer M, Franz M, Fritzenwanger M, Kabisch B, Figulla HR, Pfeifer R, Jung C.

J Diabetes Complications. 2015 Nov-Dec;29(8):1130-5. doi: 10.1016/j.jdiacomp.2015.08.010. Epub 2015 Aug 15.

PMID:
26361811
10.

Outcome predictors in cardiopulmonary resuscitation facilitated by extracorporeal membrane oxygenation.

Jung C, Janssen K, Kaluza M, Fuernau G, Poerner TC, Fritzenwanger M, Pfeifer R, Thiele H, Figulla HR.

Clin Res Cardiol. 2015 Aug 25. [Epub ahead of print]

PMID:
26303097
11.

Red cell distribution width and survival in patients hospitalized on a medical ICU.

Fujita B, Franz M, Figulla HR, Pfeifer R, Kabisch B, Fritzenwanger M, Jung C.

Clin Biochem. 2015 Nov;48(16-17):1048-52. doi: 10.1016/j.clinbiochem.2015.07.011. Epub 2015 Jul 10.

PMID:
26169241
12.

[Interventions at the tricuspid valve: What is possible?].

Lauten A, Figulla HR.

Herz. 2015 Aug;40(5):759-64. doi: 10.1007/s00059-015-4332-1. German.

PMID:
26135466
13.

Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.

Franz M, Doll F, Grün K, Richter P, Köse N, Ziffels B, Schubert H, Figulla HR, Jung C, Gummert J, Renner A, Neri D, Berndt A.

Int J Cardiol. 2015 Sep 15;195:311-22. doi: 10.1016/j.ijcard.2015.05.144. Epub 2015 May 29.

PMID:
26056964
14.

Triple transcatheter and surgical valve replacement: a 'hybrid' approach to valvular heart disease.

Lauten A, Doenst T, Figulla HR.

Eur Heart J. 2015 Jun 3. pii: ehv241. [Epub ahead of print] No abstract available.

PMID:
26040802
15.

Decrease in circulating dendritic cell precursors in patients with peripheral artery disease.

Kretzschmar D, Rohm I, Schäller S, Betge S, Pistulli R, Atiskova Y, Figulla HR, Yilmaz A.

Mediators Inflamm. 2015;2015:450957. doi: 10.1155/2015/450957. Epub 2015 Apr 15.

16.

[Interventional therapy of heart valve diseases: future perspectives].

Figulla HR, Lauten A.

Herz. 2015 Apr;40(2):215-23. doi: 10.1007/s00059-015-4207-5. Review. German.

PMID:
25822420
17.

Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U; IABP-SHOCK II Trial Investigators.

Am Heart J. 2015 Apr;169(4):e7-8. doi: 10.1016/j.ahj.2015.01.009. Epub 2015 Jan 30. No abstract available.

PMID:
25819870
18.

Investigation of bacterial translocation in chronic ischemic heart failure in the rat.

Betge S, Stingl M, Pfister W, Figulla HR, Jung C.

Clin Lab. 2015;61(1-2):93-100.

PMID:
25807643
19.

QT variability improves risk stratification in patients with dilated cardiomyopathy.

Fischer C, Seeck A, Schroeder R, Goernig M, Schirdewan A, Figulla HR, Baumert M, Voss A.

Physiol Meas. 2015 Apr;36(4):699-713. doi: 10.1088/0967-3334/36/4/699. Epub 2015 Mar 23.

PMID:
25799313
20.

Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy.

Jung C, Fuernau G, de Waha S, Eitel I, Desch S, Schuler G, Figulla HR, Thiele H.

Clin Res Cardiol. 2015 Aug;104(8):679-87. doi: 10.1007/s00392-015-0833-4. Epub 2015 Feb 27.

PMID:
25720332
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk